Metastatic potential of melanoma cells is not affected by electrochemotherapy

Melanoma Research

Volumn 21, Issue 3, 2011, Pages 196-205

  Todorovic, Vesna ^a   Sersa, Gregor ^b   Mlakar, Vid ^c   Glavac, Damjan ^c   Flisar, Karel ^c   Cemazar, Maja ^a,b  

^a UNIVERSITY OF PRIMORSKA   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

cisplatin; electrochemotherapy; electroporation; invasion; melanoma; migration

Indexed keywords

BLEOMYCIN; CISPLATIN; MATRIGEL;

ARTICLE; CANCER CONTROL; CD63 GENE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROCHEMOTHERAPY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LAMB3 GENE; LOCAL THERAPY; MELANOMA CELL; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA ISOLATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; ELECTROCHEMOTHERAPY; HUMANS; MELANOMA; MICE; MIDDLE AGED; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79955630387     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328337abd7     Document Type: Article

References (49)

1. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27:68-72.
2. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1:841-845.
3. Teissie J, Escoffre JM, Rols MP, Golzio M. Time dependence of electric field effects on cell membranes. A review for a critical selection of pulse duration for therapeutical applications. Radiol Oncol 2008; 42:196-206.
4. Cemazar M, Sersa G, Miklavcic D. Electrochemotherapy with cisplatin in the treatment of tumour cells resistant to cisplatin. Anticancer Res 1998; 18:4463-4466. (Pubitemid 29043677)
5. Orlowski S, Belehradek J Jr, Paoletti Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37:4727-4733. (Pubitemid 19006314)
6. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11:201-208. (Pubitemid 30258800)
7. Cemazar M, Miklavcic D, Mir LM, Belehradek J Jr, Bonnay M, Fourcault D, et al. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Eur J Cancer 2001; 37:1166-1172.
8. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 2000; 6:863-867. (Pubitemid 30159341)
9. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastasis. Melanoma Res 2000; 10:381-385.
10. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in the treatment of tumours. EJSO 2008; 34:232-240.
11. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa G. Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients. Radiol Oncol 1995; 29:229-235.
12. Brown LM, Welch DR, Rannels SR. B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy. Clin Exp Metastasis 2002; 19:369-376. (Pubitemid 34876204)
13. Goetze K, Scholz M, Taucher-Scholz G, Mueller-Klieser W. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro. Int J Radiat Biol 2007; 83:889-896. (Pubitemid 350219105)
14. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis 2009; 26:19-34.
15. Zupanic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy. Radiol Oncol 2008; 42:93-101. (Pubitemid 351841993)
16. Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, et al. Electrochemotherapy on liver tumours in rabbits. Br J Cancer 1998; 77:2104-2111. (Pubitemid 28263929)
17. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 2006; 4:S3-S13.
18. Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15:2215-2222.
19. Rouleau C, Menon K, Boutin P, Guyre C, Yoshida H, Kataoka S, et al. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution. Int J Oncol 2008; 32:739-748. (Pubitemid 351780584)
20. Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, et al. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int J Cancer 2004; 110:15-21. (Pubitemid 38507199)
21. Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regresion analysis by local fitting. J Am Stat Assoc 1988; 83:596-610.
22. Kranjc S, Cemazar M, Grosel A, Pipan Z, Sersa G. Effect of electroporation on radiosensitization with cisplatin in two cell lines with different chemo- and radiosensitivity. Radiol Oncol 2003; 37:101-107.
23. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-Diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55:3450-3455.
24. Kambe M, Arita D, Kikuchi H, Funato T, Tezuka F, Gamo M, et al. Enhancement of the efficacy of anticancer drugs with electroporation: successful electrochemotherapy against gastric cancer cell lines in vivo and in vitro. Int J Clin Oncol 1997; 2:111-117. (Pubitemid 127730550)
25. Ogihara M, Yamaguchi O. Potentiation of effects of anticancer agents by local electric pulses in murine bladder cancer. Urol Res 2000; 28:391-397. (Pubitemid 32039609)
26. Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, Sersa G. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 2001; 84:565-570. (Pubitemid 32215887)
27. Mir LM. Bases and rationale of the electrochemotherapy. EJC Suppl 2006; 4:S38-S44.
28. Sersa G, Stabuc B, Cemazar M, Janèar B, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998; 34:1213-1218. (Pubitemid 28342112)
29. Snoj M, Rudolf Z, Paulin-Kosir SM, Cemazar M, Snoj R, Sersa G. Long lasting complete response in melanoma treated by electrochemotherapy. EJC Suppl 2006; 4:S26-S28.
30. Roh JL, Sung MW, Kim KH. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin. Head Neck 2005; 27:326-332. (Pubitemid 40418605)
31. Hofer SOP, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression. A probable role in recurrence after tumor resection. Arch Surg 1998; 133:383-389. (Pubitemid 28193522)
32. Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, et al. Particle irradiation supresses metastatic potential of cancer cells. Cancer Res 2005; 65:113-120. (Pubitemid 40070802)
33. Rofstad EK, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 2004; 64:13-18. (Pubitemid 38114074)
34. Wild-Bode C, Weller M, Rimmer A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61:2744-2750. (Pubitemid 32685864)
35. Wach F, Eyrich AM, Wustrow T, Krieg T, Hein R. Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro. J Dermatol Sci 1996; 12:118-126. (Pubitemid 26201796)
36. Huttenlocher A, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol 1995; 7:697-706.
37. Hojman P, Zibert JR, Gissel H, Eriksen J, Gehl J. Gene expression profiles in skeletal muscle after gene electrotransfer. BMC Mol Biol 2007; 8:56-67.
38. Rubenstrunk A, Mahfoudi A, Scherman D. Delivery of electric pulses for DNA electrotransfer to mouse muscle does not induce the expression of stress related genes. Cell Biol Toxicol 2004; 20:25-31. (Pubitemid 38478128)
39. Mlakar V, Todorovic V, Cemazar M, Glavac D, Sersa G. Electric pulses used in electrochemotherapy and electrogene therapy do not significantly change the expression profile of genes involved in the development of cancer in malignant melanoma. BMC Cancer 2009; 9:299-306.
40. Lugassy C, Shahsafaei A, Bonitz P, Busam KJ, Barnhill RL. Tumour microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol 1999; 26:222-226. (Pubitemid 29296627)
41. Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumour growth and invasion. Cancer Sci 2006; 97:91-98. (Pubitemid 43379475)
42. Tsuji T, Kawada Y, Kai-Murozono M, Komatsu S, Han SA, Takeuchi K, et al. Regulation of melanoma cell migration and invasion by laminin-5 and a3b1 integrin (VLA-3). Clin Exp Metastasis 2002; 19:127-134. (Pubitemid 34264082)
43. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001; 94:763-767. (Pubitemid 33032821)
44. Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 2009; 9:40-55.
45. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, et al. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumour progression. Cancer Res 1988; 48:2955-2962.
46. Jang HI, Lee H. A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med 2003; 35:317-323. (Pubitemid 37152647)
47. Radford KJ, Mallesch J, Hersev P. Supression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 1995; 62:631-635.
48. Radford KJ, Thorne RF, Hersey P. Regulation of tumour cell motility and migration by CD63 in a human melanoma cell line. J Immunol 1997; 158:3353-3358. (Pubitemid 127484053)
49. Boucheix C, Thien Duc GH, Jasmin C, Rubinstein E. Tetraspanins and malignancy. Expert Rev Mol Med 2001; 3:1-17.